InvestorsHub Logo
Followers 12
Posts 616
Boards Moderated 0
Alias Born 05/06/2016

Re: None

Monday, 10/05/2020 8:42:05 AM

Monday, October 05, 2020 8:42:05 AM

Post# of 232880
I’m almost hoping that Trump doesn’t receive leronlimab (and not because I despise him).

Follow me here for a second:

Trump is at an extremely high risk factor for succumbing to Covid. He’s male, 74, obese, and likely had TIAs or a minor stroke recently (evidenced by his unexplained November 2019 Walter Reed visit and subsequent instances of neurological impairment [inability to easily maneuver a ramp, inability to drink a cup of water with a single hand, and his odd gait in a couple of videos] over the following months). So I’m going to assume he has metabolic dysfunction and advanced atherosclerosis on top of his other risk factors. I’m going to also assume he is in a severe/critical state because his doctor would not have (or at least should not have) administered dexamethasone if he was in a mild/moderate state. We also know his oxygen levels have been dropping in recent days.

So now we have a high risk patient, in a severe state and coming up to the worst days of the virus, being given steroids (which suppress immune function, and we have not heard back regarding his last negative Covid test), regeneron’s antibody cocktail (which is still experimental and can have side effects), and a 5-day regimen of remdesivir (which can help rot the liver and kidneys).

We know that leronlimab is not the cure all be all. Some people are just too sickly and will succumb to this horrible virus. So what happens if he progresses to a critical state and then he’s administered leronlimab? Short term lift in share price? Sure. However, what would happen if he passes?

I truly hope the guy recovers from Covid..
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News